Francesco Lo‐Coco

Active 1989–2021

Also published as
Francesco Lo Coco
102
Papers
36,657
Citations
79
h-index
102
i10-index

Citations

Citations per year for Francesco Lo‐Coco1984: 1 citations1988: 1 citations1991: 5 citations1992: 11 citations1993: 17 citations1994: 18 citations1995: 33 citations1996: 28 citations1997: 31 citations1998: 50 citations1999: 79 citations2000: 68 citations2001: 68 citations2002: 119 citations2003: 151 citations2004: 136 citations2005: 168 citations2006: 196 citations2007: 190 citations2008: 210 citations2009: 209 citations2010: 295 citations2011: 297 citations2012: 238 citations2013: 273 citations2014: 267 citations2015: 229 citations2016: 267 citations2017: 293 citations2018: 309 citations2019: 1,291 citations2020: 1,394 citations2021: 1,277 citations2022: 876 citations2023: 653 citations2024: 892 citations2025: 303 citations2026: 3 citations1985–1987: no citations, so these years are not shown1989–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,455 citing papers, 26.1% of this breakdownChina: 1,440 citing papers, 10.9% of this breakdownGermany: 1,084 citing papers, 8.2% of this breakdownItaly: 947 citing papers, 7.1% of this breakdownUnited Kingdom: 760 citing papers, 5.7% of this breakdownFrance: 678 citing papers, 5.1% of this breakdownCanada: 428 citing papers, 3.2% of this breakdownSpain: 414 citing papers, 3.1% of this breakdownNetherlands: 404 citing papers, 3.1% of this breakdownJapan: 336 citing papers, 2.5% of this breakdownAustralia: 288 citing papers, 2.2% of this breakdownSwitzerland: 230 citing papers, 1.7% of this breakdown
0%26.1%Other 21.1%

Fields

  • Medicine55.1%
  • Biochemistry, Genetics and Molecular Biology38.4%
  • Immunology and Microbiology3.2%
  • Neuroscience0.8%
  • Computer Science0.7%
  • Nursing0.5%
  • Other1.3%

Topics

  • Acute Myeloid Leukemia Research17.1%
  • Retinoids in leukemia and cellular processes4.9%
  • Histone Deacetylase Inhibitors Research4.6%
  • Acute Lymphoblastic Leukemia research4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.4%
  • Epigenetics and DNA Methylation3.3%
  • Other62.7%

Coauthors

All papers

Open in search
  1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 5,868

  2. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 2,198

  3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2009 cited by 3,392

  4. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2003 cited by 2,662

  5. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Link, Maria Grazia Kropp, Alessandro Rambaldi, Giorgio La Nasa, Mario Luppi, Fabio Ciceri, Olimpia Finizio, Adriano Venditti, Francesco Fabbiano, Konstanze Döhner, Michaela Sauer, Arnold Ganser, Sergio Amadori, Franco Mandelli, Hartmut Döhner, Gerhard Ehninger, Richard F. Schlenk, Uwe Platzbecker - New England Journal of Medicine 2013 cited by 1,606

  6. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2019 cited by 655

  7. Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations

    Authors: , , , , , , , , , - Cell 2016 cited by 770

  8. Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 1,885

  9. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

    Authors: , , , , , , , , , , - The EMBO Journal 2001 cited by 1,881

  10. Retinoic acid receptors: From molecular mechanisms to cancer therapy

    Authors: , , , , , , , , - Molecular Aspects of Medicine 2014 cited by 421

  11. Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis

    Authors: , , , , , , , , , , , - Blood 2002 cited by 323

  12. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Antonietta Irno-Consalvo, Tiziana Ottone, Serena Lavorgna, Maria Teresa Voso, Francesco Lo‐Coco, William Arcese, Sergio Amadori - Blood 2019 cited by 215

  13. The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network

    Authors: , , , , , , - Nature 2008 cited by 540

  14. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiara Frairia, Enrico Maria Pogliani, Claudio Fozza, Alfonso Maria D’Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Sergio Amadori, Franco Mandelli, Gerhard Ehninger, Richard F. Schlenk, Francesco Lo‐Coco - Journal of Clinical Oncology 2016 cited by 392

  15. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 268

  16. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance

    Authors: , , , , , , , , , , , , , , , , , - Blood 2005 cited by 358

  17. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2013 cited by 152

  18. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Authors: , , , , , , , , , , , - Blood 2008 cited by 957

  19. Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 356

  20. A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3 -Mutated Clones in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 86

  21. MRD in AML: The Role of New Techniques

    Authors: , , , , , , - Frontiers in Oncology 2019 cited by 133

  22. Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell Lymphoma

    Authors: , , , , , , - Science 1993 cited by 687

  23. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 186

  24. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abrar Alharbi, David Allsup, Richard S. Houlston, Jean Norden, Anne M. Dickinson, Elisabeth Douglas, Clare Lendrem, Ann K. Daly, Louise Palm, Kim Piechocki, Sally Jeffries, Martin Bornhäuser, Christoph Röllig, Heidi Altmann, Leo Ruhnke, Desireé Kunadt, Lisa Wagenführ, Heather J. Cordell, Rebecca Darlay, Mette Klarskov Andersen, Maria Chiara Fontana, Giovanni Martinelli, Giovanni Marconi, Miguel Á. Sanz, José Cervera, Inés Gómez‐Seguí, Thomas Cluzeau, Chimène Moreilhon, Sophie Raynaud, Heinz Sill, Maria Teresa Voso, Francesco Lo‐Coco, Hervé Dombret, Meyling Cheok, Claude Preudhomme, Rosemary E. Gale, David C. Linch, Julia Gaal-Wesinger, András Masszi, Daniel Nowak, Wolf‐Karsten Hofmann, Amanda Gilkes, Kimmo Porkka, Jelena D. Milosevic Feenstra, Róbert Královics, David Grimwade, Manja Meggendorfer, Torsten Haferlach, Szilvia Krizsán, Csaba Bödör, Friedrich Stölzel, Kenan Onel, James M. Allan - Nature Communications 2021 cited by 43